Society for Clinical Research Sites Announces New Site Advocacy Groups

Applied Clinical Trials

Ellicott City, M.D., April 22, 2015 – The Society for Clinical Research Sites (SCRS), the global trade organization fully dedicated to representing the interests of clinical research sites, today announced new developments to its landmark Site Advocacy Group initiative. TheSite Advocacy Group (SAG) initiative enables clinical investigators and site professionals to interact directly with senior industry leaders in the exchange of perspectives and experiences on innovative ideas, processes, tools, and technologies. Since its inception in early 2014, the SAG initiative has exercised considerable impact on the clinical research landscape by inciting important dialogue between site professionals and industry leaders related to current and evolving practices.

 

“The level of engagement seen from site and industry representatives with SCRS’ SAG initiative has exceeded even our most optimistic expectations,” states Christine Pierre, SCRS President. “Sites are able to provide direct feedback and see their knowledge and perspective embraced by industry leaders. The sites’ voice truly is being heard, and SCRS is pleased to announce additional opportunities for involvement in 2015.”

SCRS Circle of Sustainability Sponsor INC Research will launch two SAGs in 2015: Investigator Payment and Scientific and Operational. SCRS Site Engagement Partner Acurian will be launching the European Centralized Enrollment and Retention SAG.

SCRS is currently partnered with TransCelerate BioPharma Inc. on the Site Qualification and Training, Risk Based Monitoring, Investigator Registry, Shared Investigator Platform, and Common Protocol Template SAGs. SCRS is also in collaboration with Global Impact Partner Lilly for the Innovation SAG.

The opportunity to participate in a SAG is available to all SCRS members. To inquire about joining a SAG, please contact Allyson Small, Director of Operations, SCRS.